Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K
April 26, 2023 12:15 ET
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, announced today that it received a notice...
China XD Plastics Company Limited Receives Nasdaq Delisting Letter and Announces Intended Appeal
September 10, 2021 16:30 ET
|
China XD Plastics Company Limited
Harbin, China, Sept. 10, 2021 (GLOBE NEWSWIRE) -- China XD Plastics Company Limited (Nasdaq: CXDC, the “Company”) today announced that it received a letter (the “Letter”) from the Listing...
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
July 11, 2019 17:28 ET
|
Ritter Pharmaceuticals, Inc.
Ritter Shares Will Continue to Trade on the Nasdaq Capital Market LOS ANGELES, July 11, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the...